Publications by authors named "Samer Albahra"

This review article builds upon the introductory piece in our seven-part series, delving deeper into the transformative potential of generative artificial intelligence (Gen AI) in pathology and medicine. The article explores the applications of Gen AI models in pathology and medicine, including the use of custom chatbots for diagnostic report generation, synthetic image synthesis for training new models, dataset augmentation, hypothetical scenario generation for educational purposes, and the use of multimodal along with multi-agent models. This article also provides an overview of the common categories within generative AI models, discussing open-source and closed-source models, as well as specific examples of popular models such as GPT-4, Llama, Mistral, DALL-E, Stable Diffusion and their associated frameworks (e.

View Article and Find Full Text PDF

Healthcare data accessibility for machine learning (ML) is encumbered by a range of stringent regulations and limitations. Using synthetic data that mirrors the underlying properties in the real data is emerging as a promising solution to overcome these barriers. We propose a fully automated synthetic tabular neural generator (STNG), which comprises multiple synthetic data generators and integrates an Auto-ML module to validate and comprehensively compare the synthetic datasets generated from different approaches.

View Article and Find Full Text PDF

AI Chat Bots such as ChatGPT are revolutionizing our AI capabilities, especially in text generation, to help expedite many tasks, but they introduce new dilemmas. The detection of AI-generated text has become a subject of great debate considering the AI text detector's known and unexpected limitations. Thus far, much research in this area has focused on the detection of AI-generated text; however, the goal of this study was to evaluate the opposite scenario, an AI-text detection tool's ability to discriminate human-generated text.

View Article and Find Full Text PDF

Machine learning (ML) is becoming an integral aspect of several domains in medicine. Yet, most pathologists and laboratory professionals remain unfamiliar with such tools and are unprepared for their inevitable integration. To bridge this knowledge gap, we present an overview of key elements within this emerging data science discipline.

View Article and Find Full Text PDF

One of the core elements of Machine Learning (ML) is statistics and its embedded foundational rules and without its appropriate integration, ML as we know would not exist. Various aspects of ML platforms are based on statistical rules and most notably the end results of the ML model performance cannot be objectively assessed without appropriate statistical measurements. The scope of statistics within the ML realm is rather broad and cannot be adequately covered in a single review article.

View Article and Find Full Text PDF

The 2019 novel coronavirus infectious disease (COVID-19) pandemic has resulted in an unsustainable need for diagnostic tests. Currently, molecular tests are the accepted standard for the detection of SARS-CoV-2. Mass spectrometry (MS) enhanced by machine learning (ML) has recently been postulated to serve as a rapid, high-throughput, and low-cost alternative to molecular methods.

View Article and Find Full Text PDF

High-quality medical data is critical to the development and implementation of machine learning (ML) algorithms in healthcare; however, security, and privacy concerns continue to limit access. We sought to determine the utility of "synthetic data" in training ML algorithms for the detection of tuberculosis (TB) from inflammatory biomarker profiles. A retrospective dataset (A) comprised of 278 patients was used to generate synthetic datasets (B, C, and D) for training models prior to secondary validation on a generalization dataset.

View Article and Find Full Text PDF

Innovations in infectious disease testing have improved our abilities to detect and understand the microbial world. The 2019 novel coronavirus infectious disease (COVID-19) pandemic introduced new innovations including non-prescription "over the counter" infectious disease tests, mass spectrometry-based detection of COVID-19 host response, and the implementation of artificial intelligence (AI) and machine learning (ML) to identify individuals infected by the severe acute respiratory syndrome - coronavirus - 2 (SARS-CoV-2). As the world recovers from the COVID-19 pandemic; these innovative solutions will give rise to a new era of infectious disease tests extending beyond the detection of SARS-CoV-2.

View Article and Find Full Text PDF

Background: Artificial intelligence (AI) and machine learning (ML) are poised to transform infectious disease testing. Uniquely, infectious disease testing is technologically diverse spaces in laboratory medicine, where multiple platforms and approaches may be required to support clinical decision-making. Despite advances in laboratory informatics, the vast array of infectious disease data is constrained by human analytical limitations.

View Article and Find Full Text PDF

Serological diagnosis of active tuberculosis (TB) is enhanced by detection of multiple antibodies due to variable immune responses among patients. Clinical interpretation of these complex datasets requires development of suitable algorithms, a time consuming and tedious undertaking addressed by the automated machine learning platform MILO (Machine Intelligence Learning Optimizer). MILO seamlessly integrates data processing, feature selection, model training, and model validation to simultaneously generate and evaluate thousands of models.

View Article and Find Full Text PDF

Artificial Intelligence (AI) and machine learning (ML) have now spawned a new field within health care and health science research. These new predictive analytics tools are starting to change various facets of our clinical care domains including the practice of laboratory medicine. Many of these ML tools and studies are also starting to populate our literature landscape as we know it but unfamiliarity of the average reader to the basic knowledge and critical concepts within AI/ML is now demanding a need to better prepare our audience to such relatively unfamiliar concepts.

View Article and Find Full Text PDF

Context.—: Delayed recognition of acute kidney injury (AKI) results in poor outcomes in military and civilian burn-trauma care. Poor predictive ability of urine output (UOP) and creatinine contribute to the delayed recognition of AKI.

View Article and Find Full Text PDF

Background: Several groups have previously developed logistic regression models for predicting delayed graft function (DGF). In this study, we used an automated machine learning (ML) modeling pipeline to generate and optimize DGF prediction models en masse.

Methods: Deceased donor renal transplants at our institution from 2010 to 2018 were included.

View Article and Find Full Text PDF

Sepsis is the primary cause of burn-related mortality and morbidity. Traditional indicators of sepsis exhibit poor performance when used in this unique population due to their underlying hypermetabolic and inflammatory response following burn injury. To address this challenge, we developed the Machine Intelligence Learning Optimizer (MILO), an automated machine learning (ML) platform, to automatically produce ML models for predicting burn sepsis.

View Article and Find Full Text PDF